What is MET stock price today?

MET (Metlife Inc) stock is trading at $72.07 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is MET stock going up or down today?

MET stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy MET stock now?

The decision to buy MET depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is MET a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for MET based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is MET stock overvalued or undervalued?

MET currently trades at a P/E ratio of 15.69 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if MET is fairly priced.

What is MET's P/E ratio?

MET has a price-to-earnings (P/E) ratio of 15.69, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is MET's market cap?

MET (Metlife Inc) has a market capitalization of $50.04 billion, making it a mid-cap stock.

What is MET's price to book ratio?

MET trades at a price-to-book (P/B) ratio of 1.75, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does MET pay dividends?

Yes, MET pays dividends with a current yield of 0.03%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is MET's dividend yield?

MET's dividend yield is 0.03%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is MET stock a good long-term investment?

MET's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is MET's revenue growth rate?

MET has shown revenue growth of 0.3% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, MET is profitable with a profit margin of 0.0%. This indicates the company generates 0.0 cents of profit for every dollar of revenue.

What are the risks of investing in MET?

Key risks for MET include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does MET compare to its competitors?

Compare MET to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize MET's performance and positioning.

What is MET's stock price target for 2026?

Our AI model provides price targets for MET based on fundamental analysis: Bull case $93.69 (+30%), Base case $82.88 (+15%), Bear case $64.86 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about MET?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for MET. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is MET's next earnings report?

MET reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

MET - Metlife Inc

NYSE * Financials * Insurance

$72.07

$-3.87 (-5.10%)

About Metlife Inc

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.

MET Key Statistics

Market Cap

$50.04B

P/E Ratio

15.69

P/B Ratio

1.75

EPS

$4.84

Dividend Yield

0.03%

Revenue Growth

+0.3%

Profit Margin

0.0%

Employees

46,000

How MET Compares to Peers

MET has the lowest P/E ratio in Insurance, suggesting it may be the most undervalued

MET has the fastest revenue growth among competitors

MET is the smallest among peers, which may offer higher growth potential

P/E Rank

of 2

Margin Rank

of 2

Growth Rank

of 2

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
MET(This stock)	$50.04B	15.7	0%	0.0%	-
AMZNAmazon Com	$2.23T	29.0	0%	0.1%	vs AMZN

Metlife Inc Company Information

Headquarters: New York; U.S.A
Website: www.metlife.com
Sector: Financials
Industry: Insurance

About Metlife Inc

MET Key Statistics

How MET Compares to Peers

Metlife Inc Company Information

Upcoming Events for MET